Integrative network pharmacology and experimental verification to reveal the anti-inflammatory mechanism of ginsenoside Rh4
Inflammation is an innate immune response to infection, and it is the main factor causing bodily injury and other complications in the pathological process. Ginsenoside Rh4 (G-Rh4), a minor ginsenoside of Panax ginseng C. A. Meyer and Panax notoginseng, has excellent pharmacological properties. Howe...
Main Authors: | Kwang-Il To, Zhen-Xing Zhu, Ya-Ni Wang, Gang-Ao Li, Yu-Meng Sun, Yang Li, Ying-Hua Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.953871/full |
Similar Items
-
Microbiota, co-metabolites, and network pharmacology reveal the alteration of the ginsenoside fraction on inflammatory bowel disease
by: Dandan Wang, et al.
Published: (2023-01-01) -
Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd
by: Xiaoping Song, et al.
Published: (2022-03-01) -
Pharmacological Properties of Ginsenoside Re
by: Xiao-Yan Gao, et al.
Published: (2022-04-01) -
Mechanisms with network pharmacology approach of Ginsenosides in Alzheimer's disease
by: Shan He, et al.
Published: (2024-03-01) -
Pharmacological potential of ginseng and its major component ginsenosides
by: Zubair Ahmed Ratan, et al.
Published: (2021-03-01)